| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Jan, 2026 | Jan, 2026 | Jan, 2026 |
| Sales | 65,120 | 12,000 | 0 | 0 | 0 |
| Sales Growth | +442.67% | unch | unch | unch | unch |
| Net Income | -54,760 | -44,100 | 0 | 0 | 0 |
| Net Income Growth | -24.17% | unch | unch | unch | unch |
Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Beta Bionics Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of solutions. Beta Bionics Inc. is based in IRVINE, Calif.
Fiscal Year End Date: 12/31